|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
118,790,000 |
Market
Cap: |
42.71(M) |
Last
Volume: |
19,275,386 |
Avg
Vol: |
8,941,637 |
52
Week Range: |
$0.3595 - $0.3595 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Novavax is a biotechnology company that promotes improved global health through the discovery, development and commercialization of vaccines to prevent serious infectious diseases. Co.'s vaccine candidates, including both its coronavirus vaccine candidate, NVX-CoV2373, and its primary influenza vaccine candidate, NanoFlu, are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 and NanoFlu include the use of Co.'s proprietary Matrix-M adjuvant.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
6,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$43,042 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
3 |
Total Shares Sold |
68,716 |
68,716 |
68,716 |
68,716 |
Total Sell Value |
$961,682 |
$961,682 |
$961,682 |
$961,682 |
Total People Sold |
2 |
2 |
2 |
2 |
Total Sell Transactions |
3 |
3 |
3 |
3 |
End Date |
2024-04-07 |
2024-01-05 |
2023-07-07 |
2022-07-07 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Glenn Gregory M |
President, R&D |
|
2021-11-26 |
4 |
AS |
$215.00 |
$454,247 |
D/D |
(2,083) |
4,061 |
|
- |
|
Glenn Gregory M |
President, R&D |
|
2021-11-16 |
4 |
AS |
$166.89 |
$1,398,180 |
D/D |
(8,250) |
4,061 |
|
- |
|
Glenn Gregory M |
President, R&D |
|
2021-11-16 |
4 |
OE |
$19.08 |
$157,410 |
D/D |
8,250 |
12,311 |
|
- |
|
Glenn Gregory M |
President, R&D |
|
2021-11-15 |
4 |
AS |
$172.02 |
$203,496 |
D/D |
(1,183) |
4,061 |
|
- |
|
Glenn Gregory M |
President, R&D |
|
2021-11-15 |
4 |
OE |
$27.60 |
$44,832 |
D/D |
1,183 |
5,244 |
|
- |
|
Glenn Gregory M |
President, R&D |
|
2021-11-09 |
4 |
AS |
$164.23 |
$1,382,160 |
D/D |
(8,250) |
4,061 |
|
- |
|
Glenn Gregory M |
President, R&D |
|
2021-11-09 |
4 |
OE |
$19.08 |
$157,410 |
D/D |
8,250 |
12,311 |
|
- |
|
Herrmann John A Iii |
EVP, Chief Legal Officer |
|
2021-11-03 |
4 |
AS |
$200.00 |
$1,000,000 |
D/D |
(5,000) |
2,760 |
|
- |
|
Herrmann John A Iii |
EVP, Chief Legal Officer |
|
2021-11-03 |
4 |
OE |
$19.08 |
$95,400 |
D/D |
5,000 |
7,760 |
|
- |
|
Glenn Gregory M |
President, R&D |
|
2021-11-02 |
4 |
AS |
$177.12 |
$1,516,552 |
D/D |
(8,250) |
4,061 |
|
- |
|
Glenn Gregory M |
President, R&D |
|
2021-11-02 |
4 |
OE |
$19.08 |
$157,410 |
D/D |
8,250 |
12,311 |
|
- |
|
Herrmann John A Iii |
EVP, Chief Legal Officer |
|
2021-11-01 |
4 |
AS |
$155.16 |
$815,422 |
D/D |
(5,000) |
2,760 |
|
- |
|
Herrmann John A Iii |
EVP, Chief Legal Officer |
|
2021-11-01 |
4 |
OE |
$19.08 |
$95,400 |
D/D |
5,000 |
7,760 |
|
- |
|
Glenn Gregory M |
President, R&D |
|
2021-10-29 |
4 |
AS |
$145.41 |
$100,871 |
D/D |
(680) |
4,061 |
|
- |
|
Glenn Gregory M |
President, R&D |
|
2021-10-26 |
4 |
D |
$134.99 |
$85,989 |
D/D |
(637) |
4,741 |
|
- |
|
Glenn Gregory M |
President, R&D |
|
2021-10-26 |
4 |
D |
$134.99 |
$8,234 |
D/D |
(61) |
5,378 |
|
- |
|
Glenn Gregory M |
President, R&D |
|
2021-10-26 |
4 |
OE |
$5.95 |
$178,009 |
D/D |
11,712 |
5,439 |
|
- |
|
Glenn Gregory M |
President, R&D |
|
2021-10-26 |
4 |
AS |
$130.93 |
$1,371,667 |
D/D |
(10,334) |
4,061 |
|
- |
|
Glenn Gregory M |
President, R&D |
|
2021-10-19 |
4 |
AS |
$161.00 |
$1,362,427 |
D/D |
(8,250) |
4,061 |
|
- |
|
Glenn Gregory M |
President, R&D |
|
2021-10-19 |
4 |
OE |
$19.08 |
$157,410 |
D/D |
8,250 |
12,311 |
|
- |
|
Glenn Gregory M |
President, R&D |
|
2021-10-15 |
4 |
AS |
$170.00 |
$201,110 |
D/D |
(1,183) |
4,061 |
|
- |
|
Glenn Gregory M |
President, R&D |
|
2021-10-15 |
4 |
OE |
$27.60 |
$44,832 |
D/D |
1,183 |
5,244 |
|
- |
|
Glenn Gregory M |
President, R&D |
|
2021-10-12 |
4 |
AS |
$161.58 |
$1,346,218 |
D/D |
(8,250) |
4,061 |
|
- |
|
Glenn Gregory M |
President, R&D |
|
2021-10-12 |
4 |
OE |
$19.08 |
$157,410 |
D/D |
8,250 |
12,311 |
|
- |
|
Glenn Gregory M |
President, R&D |
|
2021-10-05 |
4 |
AS |
$170.80 |
$1,438,895 |
D/D |
(8,250) |
4,061 |
|
- |
|
460 Records found
|
|
Page 6 of 19 |
|
|